1	Subject has a stable dose regimen of 1 to 3 marketed antiepileptic drug s AEDs with or without additional concurrent stable Vagus Nerve Stimulation VNS The VNS must have been in place for at least 6 months prior to study entry with constant settings for at least 28 days prior to the screening visit and|antiepileptic[53,66]|||||||6 months[197,205]||C0003299|932|932|antiepileptic
2	during the Baseline Phase Benzodiazepines will be counted as an AED|Benzodiazepines[330,345]||||||||||1402|1402|benzodiazepines
